The Potential and Pitfalls of using a Large Language Model such as ChatGPT or GPT-4 as a Clinical… link.medium.com/BhSHkq72IBb

🎉We’re delighted to share that Empatica has been selected from 1,500 applications as a #DigitalHealthAwards 2023 quarterfinalist in the Best in Class track in the Remote Diagnostic Device, Platform or Tool category. The Empatica Health Monitoring Platform is FDA-cleared, and

Exciting news! Sanofi is back as a sponsor for HealthTech For Care this year! They've been a long-time supporter of our initiatives. Don't miss the chance to connect with them at HealthTech Innovation Days in Paris on October 24th and 25th! #HealthTech #Sponsorship 🙌🏥💼

Congrats to #SanofiVentures portfolio companies Empatica and Click Therapeutics™ for being nominated as finalists for Best #DigitalHealth Solution and Best #Startup for 2023 respectively, at the #PrixGalien Awards —considered the industry’s equivalent of the #NobelPrize, for biomedical

🤖 GOOGLE GEMINI AI: a tool to read scientific literature, parse for new relevant papers, and even update figures with data cross referenced across multiple papers!! 🧠 THAT IS WHAT I AM TALKING ABOUT! Work smarter not harder….nah work smarter and harder!

Founders trying to hit both growth and profitability targets while raising a Series A these days

On the #digitalhealth panel #jpm24 Thomas Oxley Synchron Alexander A. Morgan, MD PhD Khosla Ventures Cris De Luca Sanofi US

Only Thomas Oxley would take a photo during the panel lol

.Forbes covers #JPM24 #digitalshowcase - #neurotech takes center stage 🔥🔥🔥 With comments from brent vaughan Cognito Therapeutics Thomas Oxley Synchron Alexander A. Morgan, MD PhD Khosla Ventures Cris De Luca Altoida, Inc. Marc Jones Beth J Hoffman Origami Therapeutics, Inc. Vivodyne Atomwise forbes.com/sites/naveenra…

Thanks Forbes for covering our #neurotech panel at #JPM24 🧠 Thomas Oxley Alexander A. Morgan, MD PhD Khosla Ventures Cris De Luca Sanofi Kimberly Ha forbes.com/sites/naveenra…

Thank you for including me in the list of Top 200 health tech leaders. @Zallud_

Looking forward to speaking Bio-IT World #venture Innovation & Partnering Conference on April 17th in #Boston and discussing future of #AI driven #tech -bio #innovation and #investment with fellow panelists Rana Lonnen Novartis, Cris De Luca Sanofi, Sofia Guerra Bessemer,

Great read on Nucleai from Allison DeAngelis.

🎉 Otsuka Scores Major Win! FDA clears the first DTx for depression 🚀 📊Read about how Otsuka's long-standing commitment to this field could potentially chart a new way forward depression treatment. portal-beta.healthxl.com/articles/49c6c… #healthcare #mentalhealth

At #BioITWorld, Cris De Luca says for #PharmaTech it’s not about investing in #GenAI, it’s about how GenAI supports the use case solving problems in drug discovery #digitalhealth

This morning, we welcomed Premium Season Members to watch training at the Revolution Training Center. 💙❤️ Interested in #NERevs Premium Season Memberships? More info ➡️ nerevs.us/4d2ofY3

Want to find out how the Empatica Health Monitoring Platform can be used in research studies? ➡️ Watch our webinar replay hosted by renowned scientist and health-tech pioneer, Dr. Rosalind Picard. What to expect: 1️⃣ In-depth science: Gain a deep understanding of the

How #AI Is Revolutionizing Drug Development By Steve Lohr in the The New York Times nytimes.com/2024/06/17/bus…

Excited for this next chapter of growth at Sanofi Ventures #Digitalhealth #AI #VentureCapital linkedin.com/posts/crisdelu…